Zentiva acquisition of Solacium and Be Well Pharma

18/3/2019
Private acquisition

Announced

18/3/2019


Overview:

  • European medicine producer Zentiva has acquired pharmaceutical company Solacium along with its subsidiary Be Well Pharma from Siyiara Enterprises and entrepreneur Tony Trasca.
  • This is Zentiva's first acquisition following its carve-out from Sanofi in 2018.

Rajeeb Gurung - Researcher

 

 

Jurisdictions:

Czech Republic
Romania

Deal type:

Private acquisition

Practice area:

M&A

Industry sector:

Pharmaceuticals and life sciences


Firms:
CMS

Party: Zentiva (Acquirer)

Lawyer: Horea Popescu


Party: Tony Trasca (Seller)


Party: Siyiara (Seller)

Lawyer: Jan Evan